Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
International Forum of Allergy & Rhinology|March 2, 2025
Elexacaftor-Tezacaftor-Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic FibrosisAmanda L Stapleton, Adam Kimple, Jennifer L Goralski, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 16, 2022
Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftorIsabelle Fajac, Cori Daines, Isabelle Durieu, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2022
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosisAmanda L Stapleton, Adam J Kimple, Jennifer L Goralski, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension studyJennifer L Goralski, Cori Daines, Jessica E Pittman, et al.Health Care Transitions|December 23, 2024
Healthcare transition readiness of families of youth with cystic fibrosis during COVID-19: A correlational multicenter analysisTyra C Girdwood, Kirsten Kainz, Susan G Silva, et al.JCI Insight|December 20, 2019
Dynamic perfluorinated gas MRI reveals abnormal ventilation despite normal FEV1 in cystic fibrosisJennifer L Goralski, Sang Hun Chung, Tyler M Glass, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 7, 2023
Association between unplanned pregnancies and maternal exacerbations in cystic fibrosisGiselle Peng, Jennifer L Taylor-Cousar, MinJae Lee, et al.Chest|September 29, 2024
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After PregnancyRaksha Jain, Giselle Peng, MinJae Lee, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 14, 2026
Psychometric validity of the 22-item sinonasal outcome test in cystic fibrosisChristine M Liu, Jakob L Fischer, Jonathan B Overdevest, et al.American Journal of Respiratory and Critical Care Medicine|March 15, 2023
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del AlleleJennifer L Goralski, Jordana E Hoppe, Marcus A Mall, et al.Pageof 5